Phorm Corporation Limited ("Phorm" or the "Company"): Equity Fundraising of Approximately £ 4.47 Million Gross

SINGAPORE--(Marketwired - Oct 8, 2014) - Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce that it has today raised, in aggregate, approximately £4.47 million before expenses via a conditional placement via Mirabaud Securities LLP ("Mirabaud Securities") of 5,910,000 new ordinary shares of nil par value each in the capital of the Company (the "Placing Shares") (the "Placing") and via a subscription for 34,720,571 new ordinary shares of nil par value each in the capital of the Company (the "Subscription Shares") (the "Subscription"), both at a price of 11 pence per new ordinary share.

Phorm intends to use the net proceeds raised from the Placing and Subscription for the group's general working capital purposes.

The closing mid-market price of the Company's existing ordinary shares on 7 October 2014 (being the latest practicable business day prior to the date of this announcement) was 11.13 pence per share.

The Placing Shares have been conditionally placed by Mirabaud Securities, as agent of the Company, with certain existing and new institutional and other investors pursuant to the Placing Agreement. Under the terms of the Placing Agreement, Mirabaud Securities will receive commission from the Company conditional on admission of the Placing Shares to trading on the AIM market operated by the London Stock Exchange plc ("AIM") and the Company will give customary warranties and undertakings to Mirabaud Securities in relation, inter alia, to its business and the performance of its duties. In addition, the Company has agreed to indemnify Mirabaud Securities in relation to certain liabilities that it may incur in undertaking the Placing. Mirabaud Securities has the right to terminate the Placing Agreement in certain circumstances prior to admission, in particular, in the event that there has been, inter alia, a material breach of any of the warranties. The Placing is not being underwritten.

The Subscription is conditional upon admission of the Subscription Shares to trading on AIM. Following admission, the Subscription Shares and the Placing Shares will represent, in aggregate, approximately 5.91 per cent. of the Company's enlarged issued ordinary share capital.

Application has been made to the London Stock Exchange plc for the Subscription Shares and the Placing Shares to be admitted to trading on AIM. It is expected that admission of the Subscription Shares will become effective and that dealings in the Subscription Shares will commence at 8.00 a.m. on 9 October 2014 and that admission of the Placing Shares and dealings in the Placing Shares will commence at 8.00 a.m. on 13 October 2014.